環旭電子(601231.SH):環海電子完成收購昶虹電子子公司60%股權
格隆匯10月31日丨環旭電子(601231.SH)公佈,公司全資孫公司環海電子股份有限公司(以下簡稱“環海電子”)與昶虹電子(蘇州)有限公司(以下簡稱“昶虹電子”)於2018年8月17日簽訂《股權轉讓協議》,環海電子向昶虹電子購買其全資子公司Chung Hong Electronics Poland Sp.Z.o.o.(以下簡稱“標的公司”)的60%股權,協議金額為人民幣7800萬元。
截至2019年10月31日,本次交易已經完成股權交割。公司已根據《股權轉讓協議》支付了全部交易款項。交割完成後,環海電子直接持有標的公司60%的股權,昶虹電子直接持有標的公司40%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.